SCHEMBL2299392

SCHEMBL2299392

O=C(O)CN(C1(c2cc(-c3ccccc3Cl)ccc2Cl)CCC1)S(=O)(=O)c1ccc(Cl)c(Cl)c1

nearest known ligand 0.65

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
DAGLA Q9Y4D2 16/20 0.65
DAGLB Q8NCG7 4/20 0.65
PSEN1 P49768 3/20 0.44
PSEN2 P49810 3/20 0.44
SPPL2A Q8TCT8 3/20 0.44
APH1B Q8WW43 3/20 0.44
NCSTN Q92542 3/20 0.44
APH1A Q96BI3 3/20 0.44
PSENEN Q9NZ42 3/20 0.44
CYP3A4 P08684 2/20 0.43
CYP2D6 P10635 2/20 0.43
CYP2C9 P11712 2/20 0.43
CYP2C19 P33261 2/20 0.43
KCNH2 Q12809 2/20 0.43
NR1I2 O75469 1/20 0.42
FFAR1 O14842 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2300635 0.83 DAGLA (0.62) DAGLADAGLBPSEN1PSEN2SPPL2A
SCHEMBL2299871 0.79 DAGLA (1.00) DAGLADAGLBPSEN1PSEN2SPPL2A
SCHEMBL2300879 0.78 DAGLA (0.73) DAGLADAGLBPSEN1PSEN2SPPL2A
SCHEMBL2298832 0.75 DAGLA (0.70) DAGLADAGLBPSEN1PSEN2SPPL2A
SCHEMBL2303316 0.73 DAGLA (0.81) DAGLADAGLBCYP3A4CYP2D6CYP2C9
SCHEMBL2299545 0.72 DAGLA (0.69) DAGLADAGLBCYP3A4CYP2D6CYP2C9
SCHEMBL2297110 0.68 DAGLA (1.00) DAGLADAGLBCYP3A4CYP2D6CYP2C9
SCHEMBL2303720 0.67 DAGLA (1.00) DAGLADAGLBCYP3A4CYP2D6CYP2C9
SCHEMBL2300570 0.66 DAGLA (1.00) DAGLADAGLBCYP3A4CYP2D6CYP2C9
SCHEMBL2299131 0.65 DAGLA (1.00) DAGLADAGLBCYP3A4CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2536694-A1 GLYCINE SULFONAMIDES FOR USE AS INHIBITORS OF DIACYLGLYCEROL LIPASE Bristol-Myers Squibb Company (US) 2012-12-26 EP disclosed
WO-2011103055-A1 GLYCINE SULFONAMIDES FOR USE AS INHIBITORS OF DIACYLGLYCEROL LIPASE BRISTOL-MYERS SQUIBB COMPANY (US) 2011-08-25 WO disclosed